182 related articles for article (PubMed ID: 33554762)
21. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
[TBL] [Abstract][Full Text] [Related]
22. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
Frecer V; Megnassan E; Miertus S
Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
[TBL] [Abstract][Full Text] [Related]
23. Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.
Schrader FC; Glinca S; Sattler JM; Dahse HM; Afanador GA; Prigge ST; Lanzer M; Mueller AK; Klebe G; Schlitzer M
ChemMedChem; 2013 Mar; 8(3):442-61. PubMed ID: 23341167
[TBL] [Abstract][Full Text] [Related]
24. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
Sharma SK; Parasuraman P; Kumar G; Surolia N; Surolia A
J Med Chem; 2007 Feb; 50(4):765-75. PubMed ID: 17263522
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
[TBL] [Abstract][Full Text] [Related]
26. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
Shah P; Siddiqi MI
SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
[TBL] [Abstract][Full Text] [Related]
27. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
28. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
[TBL] [Abstract][Full Text] [Related]
29. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
Saxena S; Durgam L; Guruprasad L
J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
[TBL] [Abstract][Full Text] [Related]
30. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
[TBL] [Abstract][Full Text] [Related]
31. An
Altharawi A; Riadi Y; Tahir Ul Qamar M
J Biomol Struct Dyn; 2023; 41(23):14450-14459. PubMed ID: 36812293
[TBL] [Abstract][Full Text] [Related]
32. Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of
Manhas A; Lone MY; Jha PC
J Biomol Struct Dyn; 2019 Oct; 37(16):4181-4199. PubMed ID: 30648473
[No Abstract] [Full Text] [Related]
33.
Evbuomwan IO; Alejolowo OO; Elebiyo TC; Nwonuma CO; Ojo OA; Edosomwan EU; Chikwendu JI; Elosiuba NV; Akulue JC; Dogunro FA; Rotimi DE; Osemwegie OO; Ojo AB; Ademowo OG; Adeyemi OS; Oluba OM
J Biomol Struct Dyn; 2024; 42(1):101-118. PubMed ID: 36974933
[TBL] [Abstract][Full Text] [Related]
34. High-throughput virtual screening approach involving pharmacophore mapping, ADME filtering, molecular docking and MM-GBSA to identify new dual target inhibitors of
Rawat R; Verma SM
J Biomol Struct Dyn; 2021 Sep; 39(14):5148-5159. PubMed ID: 32579074
[TBL] [Abstract][Full Text] [Related]
35. Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum.
Maity K; Banerjee T; Prabakaran N; Surolia N; Surolia A; Suguna K
IUBMB Life; 2011 Jan; 63(1):30-41. PubMed ID: 21280175
[TBL] [Abstract][Full Text] [Related]
36. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
Kesharwani RK; Singh DV; Misra K
J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
[TBL] [Abstract][Full Text] [Related]
37. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase.
Wadood A; Ulhaq ZU
J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582
[TBL] [Abstract][Full Text] [Related]
38. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
Penna-Coutinho J; Cortopassi WA; Oliveira AA; França TC; Krettli AU
PLoS One; 2011; 6(7):e21237. PubMed ID: 21779323
[TBL] [Abstract][Full Text] [Related]
39. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
[TBL] [Abstract][Full Text] [Related]
40. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.
Batool S; Khan ZA; Kamal W; Mushtaq G; Kamal MA
Med Chem; 2015; 11(7):687-700. PubMed ID: 25741881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
